Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Verona Pharma Plc ADR
(NQ:
VRNA
)
15.53
+0.22 (+1.44%)
Streaming Delayed Price
Updated: 12:23 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Verona Pharma Plc ADR
< Previous
1
2
3
4
Next >
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
March 01, 2024
The healthcare sector is no slouch when it comes to top-performing growth stocks.
Via
The Motley Fool
Earnings Scheduled For February 29, 2024
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Earnings Preview For Verona Pharma
February 28, 2024
Via
Benzinga
3 Stocks That Could Be Monster Winners in 2024
December 30, 2023
Don't be surprised if these three stocks take off in the new year.
Via
The Motley Fool
Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves
December 29, 2023
In recent statements to the Financial Times and The Sunday Times, GSK plc (NYSE: GSK) Chief Commercial Officer Luke Miels revealed the company's intent to pursue acquisitions within the $2 billion...
Via
Benzinga
Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal
April 08, 2023
Duality Biologics out-licensed global rights (ex-China) for two ADC candidates to BioNTech, Pfizer’s partner, for one of the two original COVID-19 vaccines in a deal worth $170 million upfront and up...
Via
Talk Markets
4 Analysts Have This to Say About Verona Pharma
March 13, 2023
Via
Benzinga
Earnings Preview For Verona Pharma
March 06, 2023
Via
Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
December 30, 2022
Via
Benzinga
BTIG Maintains Buy Rating for Verona Pharma: Here's What You Need To Know
December 20, 2022
Via
Benzinga
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 26, 2023
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth...
Via
Benzinga
Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday
March 20, 2023
HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. 89bio shares fell 5.2% to trade at $11.80 on...
Via
Benzinga
7 Biotech Stocks That Could Be the Next Big Thing
March 15, 2023
Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough.
Via
InvestorPlace
Top-Notch Verona Pharma Scores A Win In COPD — And Hits A Four-Year High
December 20, 2022
The experimental mist reduced the risk of exacerbations in patients by 36%.
Via
Investor's Business Daily
Earnings Scheduled For November 2, 2023
November 02, 2023
Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Via
Benzinga
Expert Ratings for Verona Pharma
September 01, 2023
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Earnings Scheduled For May 9, 2023
May 09, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
Via
Benzinga
PDS Biotechnology, Pulmonx, Tesla And Some Other Big Stocks Moving Lower On Tuesday
January 03, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping around 50 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why These 7 Healthcare Stocks Could Soar in 2023
January 02, 2023
These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.
Via
InvestorPlace
20 Favorite Biotech & Medical Stocks For 2023
December 28, 2022
The way these stocks are setting up, many of them look great and will be at the forefront this coming year.
Via
Talk Markets
Stock Market Falls Sharply Again As Tesla Dives, Micron Hits Chips; Nike, FedEx Strong: Weekly Review
December 23, 2022
The market uptrend is under pressure.
Via
Investor's Business Daily
7 Drug Stocks That Will Soar in 2023
December 22, 2022
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 21, 2022
Via
Benzinga
Tesla, Amazon, Nike, FedEx, Verona Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today
December 20, 2022
Major Wall Street indices closed in the green on Tuesday, albeit just marginally higher, ending a four-day losing streak as investors and traders are watching out for a much anticipated year-end rally....
Via
Benzinga
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 20, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 20, 2022
Via
Benzinga
SINT Stock Alert: What to Know About Sintx Technologies’ Reverse Stock Split
December 20, 2022
Sintx Technologies (SINT) stock is in the news Tuesday as the company enacted a reverse stock split when markets opened this morning.
Via
InvestorPlace
Why Is Verona Pharma (VRNA) Stock Up 34% Today?
December 20, 2022
Verona Pharma (VRNA) stock is rising higher on Tuesday after the company released results from a Phase 3 clinical trial.
Via
InvestorPlace
Verona Pharma Stock Garners Investors' Attention After Successful COPD Trial
December 20, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.